Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Canada
Canada: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 79.0% in 2025. ◆ Volatile
Latest (2025)
79.0%
Change on year
unchanged
World rank
112th
of 194 countries
All-time high
87.0%
in 2017
All-time low
0.0%
in 2000
Years of data
26
2000–2025
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Canada, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Canada stood at 79.0%.
That represents a change of down 8.1% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Canada peaked at 87.0% in 2017 and was at its lowest, 0.0%, in 2000.
That places Canada 112th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Canada, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 83.0% | — |
| 2013 | 86.0% | +3.6% |
| 2014 | 86.0% | +0.0% |
| 2015 | 86.0% | +0.0% |
| 2016 | 86.0% | +0.0% |
| 2017 | 87.0% | +1.2% |
| 2018 | 87.0% | +0.0% |
| 2019 | 87.0% | +0.0% |
| 2020 | 83.0% | -4.6% |
| 2021 | 83.0% | +0.0% |
| 2022 | 79.0% | -4.8% |
| 2023 | 79.0% | +0.0% |
| 2024 | 79.0% | +0.0% |
| 2025 | 79.0% | +0.0% |
Canada compared with similar countries
- Canada's 79.0% is below the median for high income countries, which is 92.0%, 86% of the median. (63 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 68.8% | 0.0% | 87.0% | 10 |
| 2020s | 80.3% | 79.0% | 83.0% | 6 |
Countries ranked near Canada
More health data for Canada
- Un projection of annual infant deaths, annual growth rate -1.79 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3588 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,083 deaths per 1,000 people (2090)
- Number of infants who die before age 1 385 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.5214 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.023 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5024 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Canada?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Canada was 79.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Canada?
- The highest recorded value was 87.0% in 2017.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Canada?
- The lowest recorded value was 0.0% in 2000.
- How does Canada rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Canada ranks 112th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Canada?
- Over the last ten years it is down 8.1%. The long-run trend across the full record is volatile.
- Where does this Canada data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).